
Raz PT 4000mg/500mg Injection
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Raz PT 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration must be performed by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on infection severity. Adherence to the prescribed regimen is crucial. Potential side effects encompass gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening symptoms warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney dysfunction, or liver impairment to your doctor; dosage adjustments or alternative therapies may be necessary. Use during pregnancy and lactation is generally considered safe under medical guidance.
Uses of Raz PT 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Raz PT 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Raz PT 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Raz PT 4000mg/500mg Injection:
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Raz PT 4000mg/500mg Injection works:
Raz PT 4000mg/500mg Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby bolstering Piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Raz PT 4000mg/500mg Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication Raz PT, formulated at a 4000mg/500mg dose, is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication, Raz PT 4000mg/500mg, presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no known threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Raz PT 4000mg/500mg Injection on driving ability is unknown. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administering Raz PT 4000mg/500mg Injection requires careful consideration. A modified dosage of Raz PT 4000mg/500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Raz PT 4000mg/500mg Injection in individuals with hepatic impairment appears to present a low risk. Existing evidence indicates that dose modification might not be necessary for this patient group. However, physician consultation is advised.
What if you forget to take Raz PT 4000mg/500mg Injection :
Should you inadvertently skip a dose of Raz PT 4000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Raz PT 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
